The Maharashtra Food and Drug Administration’s temporary suspension of action against a methanol producer has widened the public-safety questions left by Pune’s toxic liquor deaths. The case now involves not only the alleged diversion of an industrial chemical into illicit alcohol, but also the limits of regulatory independence when a ministerial appeal can pause an enforcement order.
According to a report by Civic Mirror – Pune, the FDA had cancelled the licence of A.S.K. Chemicals India Private Limited, located in the Ranjangaon industrial area, on 17 June 2026. The company challenged that decision before Maharashtra’s Food and Drug Administration Minister Narhari Zirwal. On 9 September, the minister temporarily stayed the licence-cancellation order after admitting the appeal for consideration.
The stay, as described in the report and attributed to documents obtained by the publication, was not an unconditional clearance. The company was required to ensure that its registered competent person remained present at the premises. It was also directed to maintain complete records of the receipt, storage and sale of raw materials, with no discrepancies between purchase, inventory and sales records. Other deficiencies recorded in the FDA’s 17 June order were to be corrected within 15 days of the ministerial order, followed by a compliance report to the licensing authority.
The order also instructed the licensing officer for Zone Six to conduct regular inspections of the company premises. Inspection reports were to be submitted to the competent authority every three months. If the company failed to submit the required compliance report within the prescribed period, the appeal could be decided on its merits under the relevant rule, the report said.
These conditions matter because the dispute is not simply about whether a company can continue operating while an appeal is pending. It concerns how a regulator responds when the material under oversight is alleged to have entered an illicit supply chain associated with multiple deaths. A temporary stay can preserve a company’s ability to operate while due process continues, but it also places greater importance on the quality, frequency and independence of inspections during that interim period.
The immediate public-safety context is the toxic liquor incident reported in Pune between 26 and 28 May 2026. Twenty-two people died in areas including Hadapsar in Pune and Fugewadi-Dapodi in Pimpri-Chinchwad, while several others required hospitalisation. The material supplied by Civic Mirror says investigators alleged that methanol, a poisonous industrial chemical, had been mixed with country liquor. The incident therefore exposed a chain extending beyond illegal alcohol sales: procurement of an industrial substance, its storage, movement through intermediaries and its alleged use in adulterated liquor.
Police cases were registered at Hadapsar and Dapodi before the investigation was transferred to the Maharashtra Crime Investigation Department. The report says the CID alleged an organised network involving the purchase of illicit liquor, methanol adulteration and distribution across Pune and Pimpri-Chinchwad. It further reported that methanol was allegedly supplied from a warehouse in Bhiwandi through an intermediary, while the alleged liquor supply and distribution involved individuals identified in the investigation. The owners of the Ranjangaon company, Arun Chaube and his son Abhishek Chaube, were also reported to have been arrested in connection with the alleged chemical supply chain.
On 28 October, the CID filed a chargesheet against nine arrested accused before a special MOKA court, according to the report. One suspect was said to remain absconding. These are investigation claims and allegations recorded in the criminal case; they are not findings of guilt. The chargesheet nevertheless makes the regulatory decision involving the methanol producer more consequential because it places the licensing dispute against an active criminal investigation into the alleged movement of the chemical.
The institutional question is how responsibilities are divided. The FDA is responsible for licensing and regulatory action within the framework described in the report. Its licensing authority cancelled the company’s licence after identifying deficiencies. The minister, exercising the appellate role available in the process, temporarily stayed that decision after considering the company’s appeal and preliminary documents. The CID is investigating the alleged criminal network, while the court will examine the prosecution’s case. These functions are distinct, but their decisions can affect one another in practice.
A licensing action is not the same as a criminal conviction. A regulator may act on safety, compliance or documentation deficiencies before a criminal court reaches a conclusion. Conversely, a criminal investigation may generate evidence relevant to regulatory decisions without automatically determining the outcome of a licensing appeal. The supplied report does not establish whether the minister’s order accepted the company’s explanations, rejected the FDA’s findings or merely allowed the company to remain within the process subject to conditions. That distinction should be clarified through the complete order and subsequent compliance records.
The public-interest concern is therefore less about treating a stay as proof of wrongdoing or exoneration and more about whether the system makes its reasoning visible. In a case involving an alleged toxic chemical pathway and 22 deaths, citizens need to know what deficiencies the FDA identified, what evidence the appeal authority considered, whether the company met the conditions, and what inspection reports recorded after the stay. Without those documents, it is difficult to assess whether the interim safeguards were operational or merely administrative.
The report also raises allegations about the company’s links to a Nationalist Congress Party leader and claims of political pressure to halt action. Civic Mirror explicitly states that the alleged political connections and political interference have not been independently established. They should therefore remain allegations, not conclusions. The appropriate accountability question is whether the appeal process was reasoned, documented and capable of independent scrutiny, regardless of the political identity of any person connected to the company.
This is where regulatory autonomy becomes a practical urban issue. Industrial areas such as Ranjangaon are embedded in wider regional economies. They connect manufacturing units, chemical suppliers, warehouses, transporters, workers and surrounding settlements. A failure at any point in that chain can produce consequences far beyond a factory boundary. The public usually encounters the regulatory system only after harm occurs, but prevention depends on routine licensing, inventory controls, inspections and enforcement that are often invisible when they work properly.
The reported conditions imposed on the company point to the basic controls that such a system depends on: a competent person at the site, traceable records for raw-material movement, reconciliation of purchases and sales, correction of identified deficiencies, and periodic inspections. The case does not establish whether these controls failed before the deaths, nor does it establish that the Ranjangaon company supplied the methanol allegedly used in the illicit liquor. Those questions belong to the investigation and the relevant proceedings. What it does show is that the regulatory process is now being tested against a supply-chain risk that cannot be managed by checking only the final product.
The report also notes that complaints received by the FDA increased by 557 per cent after Tukaram Mundhe took charge, attributing the rise to greater public awareness and increased enforcement activity. The supplied material does not provide the baseline period, complaint numbers or methodology behind that figure, so it cannot be used on its own to measure regulatory performance. It does, however, indicate that the administration’s enforcement posture has become part of the wider debate around the department’s functioning.
The next stage will be important for establishing what happened institutionally. The company’s compliance report, the three-monthly inspection reports, the full reasoning behind the 17 June licence cancellation and the ministerial order’s treatment of the FDA’s findings would help distinguish a lawful interim appeal from an unexplained weakening of enforcement. The CID chargesheet and subsequent court proceedings may clarify the alleged chemical supply chain, but they will not by themselves answer whether regulatory safeguards were adequate.
Pune’s toxic liquor deaths have therefore produced two connected accountability tracks. The criminal case must determine responsibility for the alleged adulteration and distribution of methanol-tainted liquor. The administrative case must establish whether the licensing and inspection system detected, documented and addressed risks in time. Until the relevant records and compliance outcomes are made clear, the central issue remains unresolved: whether Maharashtra’s regulatory architecture can independently manage a hazardous industrial supply chain when public safety, commercial operations and political accountability converge.
